JP2010509205A5 - - Google Patents

Download PDF

Info

Publication number
JP2010509205A5
JP2010509205A5 JP2009535189A JP2009535189A JP2010509205A5 JP 2010509205 A5 JP2010509205 A5 JP 2010509205A5 JP 2009535189 A JP2009535189 A JP 2009535189A JP 2009535189 A JP2009535189 A JP 2009535189A JP 2010509205 A5 JP2010509205 A5 JP 2010509205A5
Authority
JP
Japan
Prior art keywords
compound
heterocyclyl
alkyl
aryl
cor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009535189A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010509205A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2007/001356 external-priority patent/WO2008056356A2/en
Publication of JP2010509205A publication Critical patent/JP2010509205A/ja
Publication of JP2010509205A5 publication Critical patent/JP2010509205A5/ja
Pending legal-status Critical Current

Links

JP2009535189A 2006-11-07 2007-11-07 Posh及びposh−ap阻害剤としてのピリミジン誘導体 Pending JP2010509205A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85737806P 2006-11-07 2006-11-07
US95983107P 2007-07-17 2007-07-17
PCT/IL2007/001356 WO2008056356A2 (en) 2006-11-07 2007-11-07 Pyrimidine derivatives as posh and posh-ap inhibitors

Publications (2)

Publication Number Publication Date
JP2010509205A JP2010509205A (ja) 2010-03-25
JP2010509205A5 true JP2010509205A5 (enExample) 2010-12-24

Family

ID=39364907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009535189A Pending JP2010509205A (ja) 2006-11-07 2007-11-07 Posh及びposh−ap阻害剤としてのピリミジン誘導体

Country Status (6)

Country Link
US (2) US8283355B2 (enExample)
EP (1) EP2083826A4 (enExample)
JP (1) JP2010509205A (enExample)
AU (1) AU2007318922C1 (enExample)
CA (1) CA2668859A1 (enExample)
WO (1) WO2008056356A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102791273A (zh) * 2009-11-30 2012-11-21 普洛提欧罗吉克斯有限公司 小分子嘧啶衍生物及其使用方法
WO2013088445A1 (en) * 2011-12-13 2013-06-20 Proteologics Ltd Pyrimidine derivatives for treatment of inflammatory diseases
GB201415688D0 (en) * 2014-09-04 2014-10-22 Univ Edinburgh Method and Systems
JP6993318B2 (ja) * 2015-07-15 2022-02-03 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ B型肝炎ウイルス複製の調節
WO2018085208A1 (en) 2016-11-02 2018-05-11 The Research Foundation For The State University Of New York Methods of inhibiting viruses using compositions targeting tsg101-ubiquitin interaction
MA53085B1 (fr) * 2018-07-05 2022-12-30 Bayer Ag Thiophènecarboxamides substitués et analogues comme agents antibactériens
AU2020253853A1 (en) * 2019-04-02 2021-11-11 Yonsei University, University - Industry Foundation (UIF) Novel compound and method for preventing or treating of respiratory disease comprising the same as an active ingredient
CN110760597B (zh) * 2019-11-22 2022-08-23 西北农林科技大学 一种检测黄牛ncstn基因拷贝数变异的方法及其应用
TW202527955A (zh) * 2023-11-27 2025-07-16 美商尼坎醫療公司 用於經由泛素蛋白酶體途徑降解週期蛋白依賴性激酶2和週期蛋白依賴性激酶4的含有2,5-取代的嘧啶衍生物的雙功能化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5734081A (en) 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
JP2004515235A (ja) 2000-12-08 2004-05-27 ノボ ノルディスク アクティーゼルスカブ Tffペプチド
FI116940B (fi) 2001-07-20 2006-04-13 Juvantia Pharma Ltd Oy Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet
US7262185B2 (en) 2001-08-08 2007-08-28 Takeda Chemical Industries Ltd. Benzazepine derivative, process for producing the same, and use
FR2845382A1 (fr) 2002-10-02 2004-04-09 Sanofi Synthelabo Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
TW200524888A (en) * 2003-08-08 2005-08-01 Vertex Pharma Compositions useful as inhibitors of voltage-gated ion channels
US20050214751A1 (en) 2004-03-02 2005-09-29 Proteologics, Inc. Inhibition of viral maturation, methods and compositions related thereto
US7671077B2 (en) * 2004-07-19 2010-03-02 Leu-Fen Hou Lin Neuroprotective small organic molecules, compositions and uses related thereto

Similar Documents

Publication Publication Date Title
ES2657687T3 (es) Derivados de pirrolopirimidina para uso en el tratamiento de infecciones virales
AU2010244462B2 (en) Dihydroorotate - dehydrogenase inhibitors as virostatic compounds
HRP20211224T1 (hr) Derivati pirimidina za liječenje virusnih infekcija
JP2013518107A5 (enExample)
NZ627826A (en) Antiviral combinations involving (3s,11ar)-n-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
NZ597544A (en) Modified 4'-nucleosides as antiviral agents
RU2018136104A (ru) СОЕДИНЕНИЯ, ГЕТЕРОБИЦИКЛО-ЗАМЕЩЕННЫЕ-[1,2,4]ТРИАЗОЛО[1,5- c]ХИНАЗОЛИН-5-АМИНА, ОБЛАДАЮЩИЕ СВОЙСТВАМИ A2А АНТАГОНИСТОВ
RU2012117829A (ru) Фосфорамидатные производные нуклеозидов
TW200630344A (en) Tetracyclic indole derivatives as antiviral agents
JP2009526761A5 (enExample)
RU2017135467A (ru) Комбинированное лечение агонистом толл-подобного рецептора (tlr7) и ингибитором сборки капсида вируса гепатита в
WO2007029029A3 (en) Tetracyclic indole derivatives as antiviral agents
JP2010523522A5 (enExample)
MX2011012146A (es) Tieno [2,3-b] piridinas derivados como inhibidores de la replicacion viral novedosos.
DOP2015000079A (es) Análogos de 2'-cloro nucleósido para infección por vhc
EA201890236A1 (ru) Полициклические карбамоилпиридоновые соединения и их фармацевтическое применение
RU2018102449A (ru) Производные пиразоло[1,5-a]триазин-4-амина, применимые в терапии
JP2014518266A5 (enExample)
RU2015120478A (ru) Пери-карбинолы
CA2862755A1 (en) Antiviral compounds with a dibenzooxaheterocycle moiety
RU2017103656A (ru) Производные изоиндолинона, полезные в качестве противовирусных средств
US20210228601A1 (en) Broad Spectrum Antiviral and Methods of Use
JP2013224953A5 (enExample)
AR065297A1 (es) Formulaciones biodisponibles de compuestos heterociclicos
JP2013523740A5 (enExample)